Dragon Life Science Holdings Group, Inc.
NOHO
$0.00
$0.000.00%
| 05/31/2014 | 02/28/2014 | 11/30/2013 | 08/31/2013 | 05/31/2013 | |
|---|---|---|---|---|---|
| Net Income | -77.97% | 29.42% | 56.75% | 73.59% | 52.75% |
| Total Depreciation and Amortization | 298.04% | 196.73% | 100.00% | 1.99% | 15,200.00% |
| Total Amortization of Deferred Charges | -39.04% | -75.47% | -7.85% | -60.62% | 856.31% |
| Total Other Non-Cash Items | 195.19% | -29.95% | -103.23% | -100.00% | -78.94% |
| Change in Net Operating Assets | -93.15% | -89.49% | -103.84% | -85.34% | 201.73% |
| Cash from Operations | -214.67% | -646.90% | 31.50% | 49.85% | 119.00% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 200.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 183.70% | -- | -- | -- |
| Cash from Investing | -- | 196.03% | 100.00% | 100.00% | -100.00% |
| Total Debt Issued | 268.74% | -157.85% | -13.88% | -50.52% | -119.78% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 161.72% | -218.18% | 153.70% | 101.60% | -176.56% |
| Cash from Financing | 252.68% | -159.65% | 2.43% | -48.75% | -119.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 736.24% | 133.86% | 121.89% | 94.20% | -250.51% |
